×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
Mutual Fund Summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Pharma
Pharma
Ads
Govt invites proposals under PRIP scheme for industry, startup projects
Select pharma shares fall between 4-7% as Trump's tariffs on branded drugs sour sentiment
InvAscent-backed Malladi Drugs planning Rs 1,200-crore IPO, holds talks with banks
Moneycontrol Pro Panorama | A Rs 1000-crore Rx heavyweight in the making
Relief for pharma sector as govt waives mandatory re-labelling of medicines after GST rate cut
GST rate cuts to benefit players across the healthcare sector
Trump doubles tariff from Aug 27: Indian labour-intensive goods face over 50%, pharma, tech remain spared
India's pharma, chemical tariffs lower compared to China
Sun Pharma: Innovative drugs are near-term growth drivers
How Novo Nordisk lost its lead in the weight loss race
Laurus Labs: Is it time to book profit?
Cipla: Non-US markets to drive growth in the near term
Cipla Q1FY26 preview: Margin pressure likely despite double-digit India growth
Dr Reddy’s Q1FY26 preview: US headwinds may weigh on margins but revenue may see double-digit growth
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
Cohance Lifesciences Q1 PAT may dip 64.2% YoY to Rs 51.6 cr: ICICI Securities
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end
A $2 billion shot in the arm: Why Glenmark’s AbbVie deal could trigger rerating
Impending jump in patent expiries to benefit Indian pharma
Indian pharma companies sit on record cash pile, set sights on acquisitions
India’s Microbiome Moment: Where science meets tradition
Weekly tactical pick: Does this pharma major merit a look despite the regulatory noises?
Pharma stocks consolidate after volatile May, but fresh triggers to drive next leg of rally
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio